Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Active not recruiting × Gliosarcoma × Clear all

Phase

Phase 1 7 Phase 2 5 Phase NA 1 Phase EARLY_PHASE1 1 Phase 3 1 Phase 2/3 1 Phase 1/2 1

Status

Completed 53 Terminated 6 Unknown 5 Withdrawn 3 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 63 Breast Neoplasms 44 Colorectal Neoplasms 38 Neoplasms 35 Neoplasm Metastasis 27 Multiple Myeloma 25 Melanoma 25 Pancreatic Neoplasms 24 Recurrence 23 Stomach Neoplasms 22 Squamous Cell Carcinoma of Head and Neck 22 Prostatic Neoplasms 22 Lymphoma, Large B-Cell, Diffuse 22 Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Ovarian Neoplasms 20 Lymphoma, Non-Hodgkin 20 Carcinoma, Renal Cell 20 Triple Negative Breast Neoplasms 19 Lung Neoplasms 19 Leukemia, Myeloid, Acute 19 Lymphoma, Follicular 17 Leukemia, Lymphocytic, Chronic, B-Cell 17 Lymphoma 16 Glioblastoma 15 Myelodysplastic Syndromes 14 Carcinoma, Transitional Cell 14 Uterine Cervical Neoplasms 13 Advanced Solid Tumor 13 Lymphoma, Mantle-Cell 12 Leukemia 12

Interventions

Sonication 1 Drug Therapy 1 Carboplatin 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04528680 2025-07-31

SC9/ABX

Northwestern University

Phase 1/2 Active not recruiting

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡